You are here

Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Naples, Florida, 34102-5449 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Pancreatitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adult male or female

- Written informed consent

- Diagnosis of chronic pancreatitis based on imaging studies

- Persistent abdominal pain due to chronic pancreatitis

- Qualifying pain score during the pre-treatment period

- Willing to comply with study visit schedule and study requirements including for women
of child-bearing potential or male patients with female partners of child-bearing
potential, the use of 2 forms of birth control

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnant women, lactating mothers, women suspected of being pregnant and women who
wish to become pregnant during the course of the study

- Chronic pancreatitis as a complication of pancreatic cancer or acute pancreatic duct
obstruction

- Pancreatic surgery, lithotripsy or endoscopist decompression within 3 months

- History of alcoholism (within 1 year of screening) or concurrent alcohol abuse

- History of cancer in the past years

- Significant cardiac disease within 6 months

- History, diagnosis or signs and symptoms of significant neurologic disease

- Disqualifying laboratory values including Hepatitis B or C, HIV and drug test

- Other medical condition that may interfere with study endpoints or safety of the
patient as determined by the Investigator

- Known history of rheumatoid arthritis

- Avascular necrosis of the bone

- History of trauma to a major joint Evidence of osteoarthritis

NCT01146561
Pfizer
Terminated
Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Chronic Pancreatitis
NCT01146561
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now